OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Lonza Group AG/  CH0013841017  /

Nasdaq Other OTC
2024-05-16  9:51:26 PM Chg. +18.8540 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
599.0200USD +3.25% 639
Turnover: 12,372.2610		 -Bid Size: - -Ask Size: - 43.34 bill.USD - -
GlobeNewswire 04-04 Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire 2023-10-16 Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire 2023-09-07 Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings
GlobeNewswire 2021-11-02 Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strate...
GlobeNewswire 2021-09-08 Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment o...
GlobeNewswire 2021-04-14 aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
GlobeNewswire 2021-03-12 Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
GlobeNewswire 2021-01-12 Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the...
GlobeNewswire 2021-01-08 Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
GlobeNewswire 2020-12-23 Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
GlobeNewswire 2020-11-10 Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal V...
GlobeNewswire 2020-09-04 Institutional Investor Research Publishes 2020 Europe Executive Team Rankings
GlobeNewswire 2020-02-06 Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic...
GlobeNewswire 2020-02-04 Amarantus Releases Letter to Shareholders
GlobeNewswire 2020-01-30 Amarantus Acquires Majority Interest in CBD Wellness Company Hempori
GlobeNewswire 2020-01-02 Amarantus Completes Sublicense of ESS, MANF and PhenoGuard to Emerald Organic Products
GlobeNewswire 2019-12-09 Amarantus to Present at 12th Annual LD Micro Main Event
GlobeNewswire 2019-12-04 Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined w...
GlobeNewswire 2019-11-21 Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorder...
GlobeNewswire 2019-11-18 Amarantus Provides Recapitalization Update to Shareholders
GlobeNewswire 2019-11-14 Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test...
GlobeNewswire 2019-10-30 Global Primary Cells Market Analysis, Trends, and Forecasts Report 2019
GlobeNewswire 2019-10-29 Worldwide Cell Based Assay & High Content Screening Market Forecasts to 2024 - Candidate Growth, Imm...
GlobeNewswire 2019-10-24 Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Org...
GlobeNewswire 2019-10-17 Mesoblast and Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast’s Potential First U...